J9029 Instill adstiladrin, treatment dose
Also known as: adstiladrin, Instiladrin
Intravesical instillation of adstiladrin (nadofaragene firadenovec), a recombinant adenovirus vector expressing the interferon-alpha-2b gene, administered as a treatment dose.
In Plain Language
intravesical bladder cancer treatment; gene therapy for bladder cancer
Clinical Context
Used for high-grade non-muscle invasive bladder cancer (BCG-unresponsive) as direct intravesical therapy via catheter.
RVU Information
CPT J9029 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9029?
CPT J9029 (Instill adstiladrin, treatment dose) is a J Codes (Drugs) code. Intravesical instillation of adstiladrin (nadofaragene firadenovec), a recombinant adenovirus vector expressing the interferon-alpha-2b gene, administered as a treatment dose.
How is J9029 administered?
CPT J9029 is administered by a healthcare provider, typically via injection or infusion. Used for high-grade non-muscle invasive bladder cancer (BCG-unresponsive) as direct intravesical therapy via catheter. It is used by Urology, Oncology.
When is CPT J9029 used?
Used for high-grade non-muscle invasive bladder cancer (BCG-unresponsive) as direct intravesical therapy via catheter.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.